Derbend Asset Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$402K Sell
2,543
-1,013
-28% -$161K 0.2% 80
2023
Q4
$557K Buy
3,556
+274
+8% +$42K 0.32% 57
2023
Q3
$511K Sell
3,282
-950
-22% -$157K 0.35% 58
2023
Q2
$700K Buy
4,232
+122
+3% +$19.7K 0.47% 29
2023
Q1
$637K Buy
4,110
+25
+0.6% +$4.04K 0.48% 34
2022
Q4
$722K Sell
4,085
-517
-11% -$89.3K 0.58% 34
2022
Q3
$752K Sell
4,602
-799
-15% -$135K 0.6% 32
2022
Q2
$959K Sell
5,401
-429
-7% -$76.4K 0.8% 26
2022
Q1
$997K Hold
5,830
0.97% 31
2021
Q4
$997K Buy
5,830
+698
+14% +$114K 0.97% 31
2021
Q3
$829K Buy
5,132
+9
+0.2% +$1.53K 0.78% 42
2021
Q2
$844K Buy
+5,123
New +$848K 0.79% 43

Other funds holding JNJ

Derbend Asset Management's JNJ Position: Q1 2024 in Review

Derbend Asset Management reduced its Johnson & Johnson (JNJ) stake by 28% in Q1 2024, selling an estimated $161K and leaving 2,543 shares worth $402K. The position accounts for 0.2% of the portfolio, ranked #80.

Derbend Asset Management first reported a position in JNJ in Q2 2021 and has held it in 12 quarters since. The position peaked at $997K in Q1 2022. 3,848 funds tracked by Wall St. Rank hold JNJ as of Q1 2024.

  • Derbend Asset Management held 2,543 shares of Johnson & Johnson worth $402K as of Q1 2024.
  • Derbend Asset Management sold 1,013 Johnson & Johnson shares in Q1 2024, an estimated $161K.
  • Johnson & Johnson made up 0.2% of Derbend Asset Management's portfolio in Q1 2024, its #80 holding.
  • Derbend Asset Management first reported a position in Johnson & Johnson in Q2 2021 and has held it in 12 quarters since.
  • Derbend Asset Management's Johnson & Johnson position peaked at $997K in Q1 2022.
  • 3,848 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2024.

Based on Derbend Asset Management's 13F filing for Q1 2024, filed 30 Apr 2024.